Bloomios

Bloomios Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Bloomios (BLMS) as of Nov 1, 2026 is 17.96 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 45.92 % — a change of -60.89% (lower).

Cash Conversion

17.96 %

YoY

-60.89%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Bloomios is 2023 17.96 % . Cash Conversion Rate (OCF/Net Income) of Bloomios was 2022 45.92 % . It decreases by -60.89% lower compared to the previous year.

The Bloomios Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
100.00 USD
Jan 1, 2019
3.44 USD
Jan 1, 2020
-4,868.80 USD
Jan 1, 2021
4.90 USD
Jan 1, 2022
45.92 USD
Jan 1, 2023
17.96 USD
The Bloomios Cash Conversion history
YEARCash ConversionYoY
17.96 %-60.89%
45.92 %+837.43%
4.90 %-100.10%
-4,868.80 %-141,643.74%
3.44 %-96.56%
100.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Cash Conversion Rate (OCF/Net Income) of Bloomios is 17.96 % in 2023.

Cash Conversion Rate (OCF/Net Income) of Bloomios changed from 45.92 % to 17.96 %, representing a -60.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Bloomios since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Bloomios with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bloomios

All Key Metrics — Bloomios